跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Stalevo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Stalevo
Approved
STANDARD
Stalevo
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c7d13e87f56c105b
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c7d13e87f56c105b
Drug Approval Philippines Name
Stalevo
Product Name
Stalevo
Registration Number
DRP-8838
Brand Name
Stalevo
Generic Name
Levocetirizine hydrochloride
Dosage Form
Syrup
Dosage Strength
2.5mg/ 5mL
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Trading Corp
Distributor
Ambica International Trading Corp
Issuance Date
24 September 2024
Expiry Date
02 July 2030
Pharmacologic Category
Antihistamine
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c7d13e87f56c105b
Type
Standard
Back to Philippines FDA Approvals